ABI-6250
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABI-6250, covering 2025-12-04 to 2025-12-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy Participants [Phase 1]